Product Images Cisatracurium Besylate

This is a warning label for Cisatracurium Besylate Injection, USP, a paralyzing agent to be used only for IV injection. Each mL contains Cisatracurium Besylate equivalent to 2 mg of Cisatracurium. The drug must be refrigerated and protected from light. It should be discarded 21 days after removal from refrigeration even if it is not used. This single-dose vial must not be used more than once. The label also includes information on how to discard the product and the details of the distributor.*

This is a description of a medication named "Cisatracurium Besylate”. It comes in a package with 70 single-use vials, each containing 5 milliliters of medication. It is only meant to be injected through IV. The vials should be discarded if any medication is left unused. Each dosage of the medication contains 2 milligrams of Cisatracurium Besylate. The medication is a paralyzing agent and may cause respiratory failure if not used correctly. It is recommended to store the medication in the refrigerator. The medication is produced in Israel, and distributed by "Premier Healthcare Alliance, LP".*

This is a description for a Cisatracurium Besylate injection in a 20mL single-dose vial. The injection is a paralyzing agent and should be used only in ICU settings. The vial should be discarded if any unused portion is left. The injection needs to be refrigerated and protected from light. Upon removal from the refrigerator, it should be used within 21 days. The injection is sterile and nonpyrogenic. It contains 200mg/20mL with a concentration of 10mg/mL. The product was distributed by Hospira, Inc, Lake Forest, and should be administered as an IV injection.*

This is a description of a Cisatracurium Besylate injection, USP for ICU use only. The package contains 10 x 20mL Single-Gose Vials. Unused portion should be discarded. -NDCUR03-3670-T0. Refrigeration is required at 2°C to 8°C (36°F to 46°F) The medicine should be protected from light and must not be frozen. This medicine is a paralyzing agent and is for intravenous (IV) injections only. Immediate availability of facilities for artificial respiration is necessary. The product is distributed by Hospir, Inc. The brand name of the medicine is PREMIERProRx.*

This is a pharmaceutical product called Cisatracurium Besylate Injection which comes in a 10mL vial containing 20 mg of active ingredient, and 10.9% benzyl alcohol as preservative. This drug is a paralyzing agent used for intravenous injection, and it can cause respiratory arrest. The product must be refrigerated at 2-8°C and protected from light. It must not be frozen and has a shelf-life of 21 days at room temperature after removal from refrigeration. The product is distributed by Hospira, Inc, and each mL of product contains cisatracurium besylate equivalent to 2 mg of cisatracurium.*

This is a description of a medical product consisting of Cisatracurium Besylate injection (20 mg/10 mL), distributed by Hospira Inc. The product is packaged in 10ml multiple-dose vials and contains benzyl alcohol as a preservative. The recommended storage temperature is between 36 to 46°F in the carton, it should be protected from light and should not be frozen. When removed from the refrigerator, it should be used within 21 days, even if it is re-refrigerated. The text contains various lot numbers - PAR168415, FPO-2D 15 mil, and FPO-Go1 28 omil, but no useful information is provided regarding their significance.*